1-6 of 6
Huilin Tang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparable Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1RAs in Asian and White Populations: An Updated Meta-analysis of Results From Randomized Outcome Trials

Free
Huilin Tang, Stephen E. Kimmel, Steven M. Smith, Kenneth Cusi, Weilong Shi, Matthew Gurka, Almut G. Winterstein, Jingchuan Guo
Journal: Diabetes Care
Diabetes Care 2022;45(4):1007–1012
https://doi.org/10.2337/dc21-1722
Published: 29 March 2022
View article titled, Comparable Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1RAs in Asian and White Populations: An Updated Meta-analysis of Results From Randomized Outcome Trials
Open the PDF for Comparable Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1RAs in Asian and White Populations: An Updated Meta-analysis of Results From Randomized Outcome Trials in another window
Journal Articles

Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in U.S. Adults

Free
Tiansheng Wang, Jeff Y. Yang, John B. Buse, Virginia Pate, Huilin Tang, Edward L. Barnes, Robert S. Sandler, Til Stürmer
Journal: Diabetes Care
Diabetes Care 2019;42(11):2065–2074
https://doi.org/10.2337/dc19-0162
Published: 30 August 2019
View article titled, Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in U.S. Adults
Open the PDF for Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in U.S. Adults in another window
Includes: Supplementary data
Journal Articles

Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials

Free
Guangyao Li, Matthew J. Crowley, Huilin Tang, Jeff Y. Yang, Robert S. Sandler, Tiansheng Wang
Journal: Diabetes Care
Diabetes Care 2019;42(7):e119–e121
https://doi.org/10.2337/dc18-1578
Published: 21 May 2019
View article titled, Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials
Open the PDF for Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials in another window
Journal Articles

Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting

Free
Tiansheng Wang, Wenchao Lu, Dandan Li, Huilin Tang, Jeff Y. Yang, John B. Buse, Til Stürmer
Journal: Diabetes Care
Diabetes Care 2019;42(6):e89–e91
https://doi.org/10.2337/dc18-1609
Published: 10 May 2019
View article titled, Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting
Open the PDF for Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting in another window
Journal Articles

Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System

Free
Tiansheng Wang, Wenchao Lu, Huilin Tang, John B. Buse, Til Stürmer, Emily W. Gower
Journal: Diabetes Care
Diabetes Care 2019;42(2):e21–e23
https://doi.org/10.2337/dc18-1893
Published: 07 December 2018
View article titled, Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System
Open the PDF for Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System in another window
Journal Articles

Effect of Sodium–Glucose Cotransporter 2 Inhibitors on Diabetic Ketoacidosis Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials

Open Access
Huilin Tang, Dandan Li, Tiansheng Wang, Suodi Zhai, Yiqing Song
Journal: Diabetes Care
Diabetes Care 2016;39(8):e123–e124
https://doi.org/10.2337/dc16-0885
Published: 16 June 2016
View article titled, Effect of Sodium–Glucose Cotransporter 2 Inhibitors on Diabetic Ketoacidosis Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials
Open the PDF for Effect of Sodium–Glucose Cotransporter 2 Inhibitors on Diabetic Ketoacidosis Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials in another window